ResearcherUniversity of KwaZulu-NatalActive in the last 2 years

Parvesh Singh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6742-6389; OpenAlex author ID A5060468723. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Exploring Novel Coumarin-Tethered Bis-Triazoles: Apoptosis Induction in Human Pancreatic Cancer Cells, Antimicrobial Effects, and Molecular Modelling Investiga… Last author DOI 10.1002/cmdc.202400297 ↗
Synthesis of indole-tethered [1,3,4]thiadiazolo and [1,3,4]oxadiazolo[3,2-a]pyrimidin-5-one hybrids as anti-pancreatic cancer agents. Last author DOI 10.1016/j.bmcl.2020.127544 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sanjeev Dhawan Nom · 1 shared paper, 2024 · strength 0.21
- Paper Exploring Novel Coumarin-Tethered Bis-Triazoles: Apoptosis Induction in Human Pancreatic Cancer Cells, Antimicrobial Ef… DOI 10.1002/cmdc.202400297 ↗
Lalitha Gummidi · 1 shared paper, 2020 · strength 0.13
- Paper Synthesis of indole-tethered [1,3,4]thiadiazolo and [1,3,4]oxadiazolo[3,2-a]pyrimidin-5-one hybrids as anti-pancreatic … DOI 10.1016/j.bmcl.2020.127544 ↗
Arun Kumar Sharma · 1 shared paper, 2020 · strength 0.13
- Paper Synthesis of indole-tethered [1,3,4]thiadiazolo and [1,3,4]oxadiazolo[3,2-a]pyrimidin-5-one hybrids as anti-pancreatic … DOI 10.1016/j.bmcl.2020.127544 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.